BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gong Y, Wu X, Wang T, Zhao J, Liu X, Yao Z, Zhang Q, Jian X. Targeting PEPT1: a novel strategy to improve the antitumor efficacy of doxorubicin in human hepatocellular carcinoma therapy. Oncotarget 2017;8:40454-68. [PMID: 28465466 DOI: 10.18632/oncotarget.17117] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu X. SLC Family Transporters. In: Liu X, Pan G, editors. Drug Transporters in Drug Disposition, Effects and Toxicity. Singapore: Springer; 2019. pp. 101-202. [DOI: 10.1007/978-981-13-7647-4_3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
2 Miyabe J, Ohgaki R, Saito K, Wei L, Quan L, Jin C, Liu X, Okuda S, Nagamori S, Ohki H, Yoshino K, Inohara H, Kanai Y. Boron delivery for boron neutron capture therapy targeting a cancer-upregulated oligopeptide transporter. J Pharmacol Sci 2019;139:215-22. [PMID: 30833090 DOI: 10.1016/j.jphs.2019.01.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
3 Ren W, Zhou C, Liu Y, Su K, Jia L, Chen L, Li M, Ma J, Zhou W, Zhang S, Zhang D, Cong Z, Niu X, Zhang S, Shen L, Huai C, Sun X, Li G, Qin S, Guo L. Genetic associations of docetaxel-based chemotherapy-induced myelosuppression in Chinese Han population. J Clin Pharm Ther 2020;45:354-64. [PMID: 31778586 DOI: 10.1111/jcpt.13084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Zhang J, Wen H, Shen F, Wang X, Shan C, Chai C, Liu J, Li W. Synthesis and biological evaluation of a novel series of curcumin-peptide derivatives as PepT1-mediated transport drugs. Bioorganic Chemistry 2019;92:103163. [DOI: 10.1016/j.bioorg.2019.103163] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lai HW, Sasaki R, Usuki S, Nakajima M, Tanaka T, Ogura S. Novel strategy to increase specificity of ALA-Induced PpIX accumulation through inhibition of transporters involved in ALA uptake. Photodiagnosis and Photodynamic Therapy 2019;27:327-35. [DOI: 10.1016/j.pdpdt.2019.06.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Niu L, Liu L, Yang S, Ren J, Lai PBS, Chen GG. New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies. Biochim Biophys Acta Rev Cancer. 2017;1868:564-570. [PMID: 29054475 DOI: 10.1016/j.bbcan.2017.10.002] [Cited by in Crossref: 72] [Cited by in F6Publishing: 87] [Article Influence: 14.4] [Reference Citation Analysis]
7 Gong Y, Zhang J, Wu X, Wang T, Zhao J, Yao Z, Zhang Q, Liu X, Jian X. Specific expression of proton-coupled oligopeptide transporter 1 in primary hepatocarcinoma-a novel strategy for tumor-targeted therapy. Oncol Lett 2017;14:4158-66. [PMID: 28943923 DOI: 10.3892/ol.2017.6724] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
8 Hu Y, Song F, Jiang H, Nuñez G, Smith DE. SLC15A2 and SLC15A4 Mediate the Transport of Bacterially Derived Di/Tripeptides To Enhance the Nucleotide-Binding Oligomerization Domain-Dependent Immune Response in Mouse Bone Marrow-Derived Macrophages. J Immunol 2018;201:652-62. [PMID: 29784761 DOI: 10.4049/jimmunol.1800210] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
9 Fernando DM, Gee CT, Griffith EC, Meyer CJ, Wilt LA, Tangallapally R, Wallace MJ, Miller DJ, Lee RE. Biophysical analysis of the Mycobacteria tuberculosis peptide binding protein DppA reveals a stringent peptide binding pocket. Tuberculosis (Edinb) 2021;132:102157. [PMID: 34894561 DOI: 10.1016/j.tube.2021.102157] [Reference Citation Analysis]
10 Schniers BK, Rajasekaran D, Korac K, Sniegowski T, Ganapathy V, Bhutia YD. PEPT1 is essential for the growth of pancreatic cancer cells: a viable drug target. Biochem J 2021;478:3757-74. [PMID: 34569600 DOI: 10.1042/BCJ20210377] [Reference Citation Analysis]
11 Li T, Wu D, Yang Y, Xiao T, Han Y, Li J, Liu T, Li L, Dai Z, Li Y, Fu X. Synthesis, pharmacological evaluation and mechanistic study of scutellarin methyl ester -4'-dipeptide conjugates for the treatment of hypoxic-ischemic encephalopathy (HIE) in rat pups. Bioorg Chem 2020;101:103980. [PMID: 32540782 DOI: 10.1016/j.bioorg.2020.103980] [Reference Citation Analysis]
12 Huang H, Wang J, Chen S, He H, Shang Y, Guo X, Lou G, Ji J, Guo M, Chen H, Yu S. SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma. Front Genet 2021;12:666607. [PMID: 34168674 DOI: 10.3389/fgene.2021.666607] [Reference Citation Analysis]
13 Kumar A, Patel S, Bhatkar D, Sarode SC, Sharma NK. A novel method to detect intracellular metabolite alterations in MCF-7 cells by doxorubicin induced cell death. Metabolomics 2021;17:3. [PMID: 33389242 DOI: 10.1007/s11306-020-01755-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhou J, Zheng X, Feng M, Mo Z, Shan Y, Wang Y, Jin J. Upregulated MMP28 in Hepatocellular Carcinoma Promotes Metastasis via Notch3 Signaling and Predicts Unfavorable Prognosis. Int J Biol Sci 2019;15:812-25. [PMID: 30906212 DOI: 10.7150/ijbs.31335] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
15 Brecht K, Schäfer AM, Meyer Zu Schwabedissen HE. Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy-Modulators of Cellular Entry or Pharmacokinetics? Cancers (Basel) 2020;12:E2263. [PMID: 32806706 DOI: 10.3390/cancers12082263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Sritharan S, Sivalingam N. A comprehensive review on time-tested anticancer drug doxorubicin. Life Sci 2021;278:119527. [PMID: 33887349 DOI: 10.1016/j.lfs.2021.119527] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
17 Wu D, Chen J, Luo K, Li H, Liu T, Li L, Dai Z, Li Y, Zhao Y, Fu X. Design, synthesis and evaluation of novel scutellarin and scutellarein-N,N-bis-substituted carbamate-l-amino acid derivatives as potential multifunctional therapeutics for Alzheimer's disease. Bioorg Chem 2022;122:105760. [PMID: 35349945 DOI: 10.1016/j.bioorg.2022.105760] [Reference Citation Analysis]